EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-12: Reporting owner Zanotti Katherine S; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-12: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-03-14: Reporting owner LIDGARD GRAHAM PETER; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-03-09: Reporting owner LIDGARD GRAHAM PETER; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-12 | Zanotti Katherine S Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,667 0 owned after | $3.43 exercise price | 2018-11-14 | |
| 2018-11-12 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −163,514 0 owned after | $0.83 exercise price | 2018-11-14 | |
| 2018-03-14 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,163 0 owned after | $13.96 exercise price | 2018-03-15 | |
| 2018-03-09 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,125 6,125 owned after | $23.38 exercise price | 2018-03-13 | |
| 2018-02-27 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,700 16,700 owned after | $44.37 exercise price | 2018-03-02 | |
| 2018-02-27 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $44.37 exercise price | 2018-02-28 | |
| 2018-02-27 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,700 16,700 owned after | $44.37 exercise price | 2018-02-28 | |
| 2018-02-27 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,700 16,700 owned after | $44.37 exercise price | 2018-02-28 | |
| 2018-02-27 | COWARD D SCOTT Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,700 16,700 owned after | $44.37 exercise price | 2018-02-28 | |
| 2018-02-27 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +68,300 68,300 owned after | $44.37 exercise price | 2018-02-28 | |
| 2018-02-26 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,587 7,163 owned after | $13.96 exercise price | 2018-03-02 | |
| 2018-02-26 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,750 27,500 owned after | $5.70 exercise price | 2018-03-02 | |
| 2018-02-26 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,587 7,163 owned after | $13.96 exercise price | 2018-02-28 | |
| 2018-02-26 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,750 27,500 owned after | $5.70 exercise price | 2018-02-28 | |
| 2018-02-23 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,250 60,750 owned after | $21.68 exercise price | 2018-02-27 | |
| 2018-02-09 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −101,488 163,514 owned after | $0.83 exercise price | 2018-02-13 | |
| 2018-01-23 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −110,439 265,002 owned after | $0.83 exercise price | 2018-01-25 | |
| 2018-01-12 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −125,402 375,441 owned after | $0.83 exercise price | 2018-01-17 |